Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

This study has been completed.

Study NCT00055562 Information provided by Celgene Corporation

First Received: March 5, 2003 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	December 2004
Estimated Primary Completion Date:	No date given